
    
      The study is open label randomized interventional phase 3 clinical trial. Patients with
      confirmed Covid-19 cases who was hospitalized in Two university isolation hospitals (Ain
      Shams University and Assiut University ) assigned hospitals for isolation.

      The included patients receive. Intervention group: Remdesivir loading dose of 200 mg
      intravenously followed by 100 mg/day intravenously for 5 to 10days + Methylprednisolone
      1-2mg/kg for 5-7 days Control group: standard of care without Remdesivir
    
  